14P Study of the association of co-medications on the occurrence and severity of cytokine release syndrome in clinical trials involving anti-CD3 bispeficic antibodies
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
14P Study of the association of co-medications on the occurrence and severity of cytokine release syndrome in clinical trials involving anti-CD3 bispeficic antibodies | Researchclopedia